Yahoo Web Search

  1. Yahoo Finance Results

  2. The Brain & Behavior Research Foundation , the world's largest private funder of mental health research grants, honored ten scientists with its 2018 Outstanding Achievement Prizes ...

  3. Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag

    Zacks via Yahoo FinanceOct 31 15:17 PM

    Aduro has a research and license agreement with Janssen, a subsidiary of Johnson & Johnson JNJ, for developing ADU-214 and ADU-741. Aduro has a collaboration and license agreement ...

  4. The rise was due to variation in costs for the proportionate share of clinical development of imetelstat under collaboration with Janssen. In September, Geron announced that Johnson & ...

  5. VIVUS Inc. VVUS reported a loss of 87 cents per share for the third quarter of 2018, wider than a loss of 57 cents in the year-ago period but narrower than the Zacks Consensus Estimate of $1.10 ...

  6. TESARO (TSRO) Q3 Earnings Beat, Revenues Miss, Shares Up

    Zacks via Yahoo FinanceNov 02 18:53 PM

    TESARO, Inc. TSRO incurred a loss of $2.49 per share in the third quarter of 2018, which was narrower than the Zacks Consensus Estimate of a loss of $2.62. The company had recorded a significantly ...

  7. Edited Transcript of AOX.DE earnings conference call or presentation 6-Nov-18 9:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 06 18:30 PM

    KG, Research Division - Analyst * Markus Scheufler Deutsche Bank AG, Research Division - Head of the Pan-European Real Estate Equity Research Team * Thomas Neuhold Kepler ...

  8. Edited Transcript of TEG.DE earnings conference call or presentation 30-Oct-18 9:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 01 0:19 AM

    Please have in mind that we were net seller in the first 9 months of 2018, so the portfolio is -- so the total units of the portfolio were slightly lower than at the beginning of the year, simply ...

  9. Trippy depression treatment? Hopes and hype for ketamine

    Associated Press via Yahoo FinanceOct 31 16:11 PM

    Now the chameleon drug ketamine is finding new life as an unapproved treatment for depression and suicidal behavior. Chicago preschool teacher Lauren Pestikas long struggled with depression ...

  10. Edited Transcript of HALO earnings conference call or presentation 6-Nov-18 9:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 07 4:25 AM

    As of today, we have a broad ENHANZE pipeline with our partners that includes 2 products in Phase III clinical testing, 4 products in Phase I clinical testing, 1 product that has started screening ...

  11. Edited Transcript of DVAX earnings conference call or presentation 5-Nov-18 9:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 06 6:09 AM

    ... - CFO, Chief Business Officer & Senior VP * Robert Janssen Dynavax Technologies Corporation - Chief Medical Officer & ... Corey Abrahams RBC Capital Markets, LLC, Research Division - Senior Analyst * Joseph John-Charles Thome ...